ID: MRFR/HC/9236-HCR | 120 Pages | Author: Rahul Gotadki | March 2024
TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Techniques
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Porter’s Five Forces Analysis
5.1.1. Bargaining Power of Suppliers
5.1.2. Bargaining Power of Buyers
5.1.3. Threat of New Entrants
5.1.4. Threat of Substitutes
5.1.5. Intensity of Rivalry
5.2. Value Chain Analysis
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Impact on Supply Chain
5.3.3. Regional Impact
5.3.4. Opportunity and Threat Analysis
6. GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET, BY SAMPLE
6.1. Overview
6.2. Sterile Drugs
Market Estimates & Forecast, by Region, 2022–2030
Market Estimates & Forecast, by Country, 2022–2030
6.3. Medical Devices
Market Estimates & Forecast, by Region, 2022–2030
Market Estimates & Forecast, by Country, 2022–2030
6.4. Biologics
Market Estimates & Forecast, by Region, 2022–2030
Market Estimates & Forecast, by Country, 2022–2030
7. GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET, BY PRODUCT TYPE
7.1. Overview
7.2. Instruments
Market Estimates & Forecast, by Region, 2022–2030
Market Estimates & Forecast, by Country, 2022–2030
7.3. Kits & Reagents
Market Estimates & Forecast, by Region, 2022–2030
Market Estimates & Forecast, by Country, 2022–2030
7.4. Services
Market Estimates & Forecast, by Region, 2022–2030
Market Estimates & Forecast, by Country, 2022–2030
8. GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET, BY TYPE
8.1. Overview
8.2. In-house
Market Estimates & Forecast, by Region, 2022–2030
Market Estimates & Forecast, by Country, 2022–2030
8.3. Outsourcing
Market Estimates & Forecast, by Region, 2022–2030
Market Estimates & Forecast, by Country, 2022–2030
9. GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET, BY TEST TYPE
9.1. Overview
9.2. Sterility Testing
Market Estimates & Forecast, by Region, 2022–2030
Market Estimates & Forecast, by Country, 2022–2030
9.3. Bioburden Testing
Market Estimates & Forecast, by Region, 2022–2030
Market Estimates & Forecast, by Country, 2022–2030
9.4. Bacterial Endotoxin Testing
Market Estimates & Forecast, by Region, 2022–2030
Market Estimates & Forecast, by Country, 2022–2030
10. GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET, BY END USER
10.1. Overview
10.2. Compounding Pharmacies
Market Estimates & Forecast, by Region, 2022–2030
Market Estimates & Forecast, by Country, 2022–2030
10.3. Medical Devices Companies
Market Estimates & Forecast, by Region, 2022–2030
Market Estimates & Forecast, by Country, 2022–2030
10.4. Pharmaceutical Companies
Market Estimates & Forecast, by Region, 2022–2030
Market Estimates & Forecast, by Country, 2022–2030
10.5. Others
Market Estimates & Forecast, by Region, 2022–2030
Market Estimates & Forecast, by Country, 2022–2030
11. GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET, BY REGION
11.1. Overview
11.2. North America
11.2.1. US
11.2.2. Canada
11.3. Europe
11.3.1. Germany
11.3.2. France
11.3.3. Italy
11.3.4. Spain
11.3.5. UK
11.3.6. Rest of Europe
11.4. Asia-Pacific
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. Australia
11.4.5. South Korea
11.4.6. Rest of Asia-Pacific
11.5. Rest of the World
11.5.1. Middle East
11.5.2. Africa
11.5.3. Latin America
12. COMPANY LANDSCAPE
12.1. Overview
12.2. Competitive Analysis
12.3. Market Share Analysis
12.4. Major Growth Strategy in the Global Pharmaceutical Sterility Testing Market
12.5. Competitive Benchmarking
12.6. Leading Players in terms of Number of Developments in the Global Pharmaceutical Sterility Testing Market
12.7. Key developments and Growth Strategies
12.7.1. New Product Launch/Service Deployment
12.7.2. Mergers & Acquisitions
12.7.3. Joint Ventures
12.8. Major Players Financial Matrix
12.8.1. Sales & Operating Income, 2020
12.8.2. Major Players R&D Expenditure, 2020
13. COMPANY PROFILES
13.1. Merck KGaA
13.1.1. Company Overview
13.1.2. Key Financials
13.1.3. Products Offered
13.1.4. Key Developments
13.1.5. SWOT Analysis
13.1.6. Key Strategies
13.2. Rapid Micro Biosystems
13.2.1. Company Overview
13.2.2. Key Financials
13.2.3. Products Offered
13.2.4. Key Developments
13.2.5. SWOT Analysis
13.2.6. Key Strategies
13.3. Sartorius AG
13.3.1. Company Overview
13.3.2. Key Financials
13.3.3. Products Offered
13.3.4. Key Developments
13.3.5. SWOT Analysis
13.3.6. Key Strategies
13.4. Solvias AG
13.4.1. Company Overview
13.4.2. Key Financials
13.4.3. Products Offered
13.4.4. Key Developments
13.4.5. SWOT Analysis
13.4.6. Key Strategies
13.5. SGS SA
13.5.1. Company Overview
13.5.2. Key Financials
13.5.3. Products Offered
13.5.4. Key Developments
13.5.5. SWOT Analysis
13.5.6. Key Strategies
13.6. Boston Analytical
13.6.1. Company Overview
13.6.2. Key Financials
13.6.3. Products Offered
13.6.4. Key Developments
13.6.5. SWOT Analysis
13.6.6. Key Strategies
13.7. BioMérieux, Inc.
13.7.1. Company Overview
13.7.2. Key Financials
13.7.3. Products Offered
13.7.4. Key Developments
13.7.5. SWOT Analysis
13.7.6. Key Strategies
13.8. Charles River Laboratories International, Inc.
13.8.1. Company Overview
13.8.2. Key Financials
13.8.3. Products Offered
13.8.4. Key Developments
13.8.5. SWOT Analysis
13.8.6. Key Strategies
13.9. Thermo Fisher Scientific, Inc.
13.9.1. Company Overview
13.9.2. Key Financials
13.9.3. Products Offered
13.9.4. Key Developments
13.9.5. SWOT Analysis
13.9.6. Key Strategies
13.10. Pace Analytical Services, LLC
13.10.1. Company Overview
13.10.2. Key Financials
13.10.3. Products Offered
13.10.4. Key Developments
13.10.5. SWOT Analysis
13.10.6. Key Strategies
13.11. Toxikon, Inc.
13.11.1. Company Overview
13.11.2. Key Financials
13.11.3. Products Offered
13.11.4. Key Developments
13.11.5. SWOT Analysis
13.11.6. Key Strategies
13.12. Sotera Health
13.12.1. Company Overview
13.12.2. Key Financials
13.12.3. Products Offered
13.12.4. Key Developments
13.12.5. SWOT Analysis
13.12.6. Key Strategies
13.13. Pacific Biolabs Inc.
13.13.1. Company Overview
13.13.2. Key Financials
13.13.3. Products Offered
13.13.4. Key Developments
13.13.5. SWOT Analysis
13.13.6. Key Strategies
13.14. STRERIS Corporation
13.14.1. Company Overview
13.14.2. Key Financials
13.14.3. Products Offered
13.14.4. Key Developments
13.14.5. SWOT Analysis
13.14.6. Key Strategies
13.15. WuXi AppTec
13.15.1. Company Overview
13.15.2. Key Financials
13.15.3. Products Offered
13.15.4. Key Developments
13.15.5. SWOT Analysis
13.15.6. Key Strategies
14. APPENDIX
14.1. References
14.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET SYNOPSIS, 2022–2030
TABLE 2 GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET ESTIMATES & FORECAST, 2022– 2030 (USD MILLION)
TABLE 3 GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET, BY SAMPLE, 2022–2030 (USD MILLION)
TABLE 4 GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)
TABLE 5 GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 6 GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)
TABLE 7 GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 8 NORTH AMERICA: PHARMACEUTICAL STERILITY TESTING MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 9 NORTH AMERICA: PHARMACEUTICAL STERILITY TESTING MARKET, BY SAMPLE, 2022–2030 (USD MILLION)
TABLE 10 NORTH AMERICA: PHARMACEUTICAL STERILITY TESTING MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)
TABLE 11 NORTH AMERICA: PHARMACEUTICAL STERILITY TESTING MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 12 NORTH AMERICA: PHARMACEUTICAL STERILITY TESTING MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)
TABLE 13 NORTH AMERICA: PHARMACEUTICAL STERILITY TESTING MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 14 US: PHARMACEUTICAL STERILITY TESTING MARKET, BY SAMPLE, 2022–2030 (USD MILLION)
TABLE 15 US: PHARMACEUTICAL STERILITY TESTING MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)
TABLE 16 US: PHARMACEUTICAL STERILITY TESTING MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 17 US: PHARMACEUTICAL STERILITY TESTING MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)
TABLE 18 US: PHARMACEUTICAL STERILITY TESTING MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 19 CANADA: PHARMACEUTICAL STERILITY TESTING MARKET, BY SAMPLE, 2022–2030 (USD MILLION)
TABLE 20 CANADA: PHARMACEUTICAL STERILITY TESTING MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)
TABLE 21 CANADA: PHARMACEUTICAL STERILITY TESTING MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 22 CANADA: PHARMACEUTICAL STERILITY TESTING MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)
TABLE 23 CANADA: PHARMACEUTICAL STERILITY TESTING MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 24 EUROPE: PHARMACEUTICAL STERILITY TESTING MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 25 EUROPE: PHARMACEUTICAL STERILITY TESTING MARKET, BY SAMPLE, 2022–2030 (USD MILLION)
TABLE 26 EUROPE: PHARMACEUTICAL STERILITY TESTING MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)
TABLE 27 EUROPE: PHARMACEUTICAL STERILITY TESTING MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 28 EUROPE: PHARMACEUTICAL STERILITY TESTING MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)
TABLE 29 EUROPE: PHARMACEUTICAL STERILITY TESTING MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 30 GERMANY: PHARMACEUTICAL STERILITY TESTING MARKET, BY SAMPLE, 2022–2030 (USD MILLION)
TABLE 31 GERMANY: PHARMACEUTICAL STERILITY TESTING MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)
TABLE 32 GERMANY: PHARMACEUTICAL STERILITY TESTING MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 33 GERMANY: PHARMACEUTICAL STERILITY TESTING MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)
TABLE 34 GERMANY: PHARMACEUTICAL STERILITY TESTING MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 35 FRANCE: PHARMACEUTICAL STERILITY TESTING MARKET, BY SAMPLE, 2022–2030 (USD MILLION)
TABLE 36 FRANCE: PHARMACEUTICAL STERILITY TESTING MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)
TABLE 37 FRANCE: PHARMACEUTICAL STERILITY TESTING MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 38 FRANCE: PHARMACEUTICAL STERILITY TESTING MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)
TABLE 39 FRANCE: PHARMACEUTICAL STERILITY TESTING MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 40 ITALY: PHARMACEUTICAL STERILITY TESTING MARKET, BY SAMPLE, 2022–2030 (USD MILLION)
TABLE 41 ITALY: PHARMACEUTICAL STERILITY TESTING MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)
TABLE 42 ITALY: PHARMACEUTICAL STERILITY TESTING MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 43 ITALY: PHARMACEUTICAL STERILITY TESTING MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)
TABLE 44 ITALY: PHARMACEUTICAL STERILITY TESTING MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 45 SPAIN: PHARMACEUTICAL STERILITY TESTING MARKET, BY SAMPLE, 2022–2030 (USD MILLION)
TABLE 46 SPAIN: PHARMACEUTICAL STERILITY TESTING MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)
TABLE 47 SPAIN: PHARMACEUTICAL STERILITY TESTING MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 48 SPAIN: PHARMACEUTICAL STERILITY TESTING MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)
TABLE 49 SPAIN: PHARMACEUTICAL STERILITY TESTING MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 50 UK: PHARMACEUTICAL STERILITY TESTING MARKET, BY SAMPLE, 2022–2030 (USD MILLION)
TABLE 51 UK: PHARMACEUTICAL STERILITY TESTING MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)
TABLE 52 UK: PHARMACEUTICAL STERILITY TESTING MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 53 UK: PHARMACEUTICAL STERILITY TESTING MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)
TABLE 54 UK: PHARMACEUTICAL STERILITY TESTING MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 55 REST OF EUROPE: PHARMACEUTICAL STERILITY TESTING MARKET, BY SAMPLE, 2022–2030 (USD MILLION)
TABLE 56 REST OF EUROPE: PHARMACEUTICAL STERILITY TESTING MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)
TABLE 57 REST OF EUROPE: PHARMACEUTICAL STERILITY TESTING MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 58 REST OF EUROPE: PHARMACEUTICAL STERILITY TESTING MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)
TABLE 59 REST OF EUROPE: PHARMACEUTICAL STERILITY TESTING MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 60 ASIA-PACIFIC: PHARMACEUTICAL STERILITY TESTING MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 61 ASIA-PACIFIC: PHARMACEUTICAL STERILITY TESTING MARKET, BY SAMPLE, 2022–2030 (USD MILLION)
TABLE 62 ASIA-PACIFIC: PHARMACEUTICAL STERILITY TESTING MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)
TABLE 63 ASIA-PACIFIC: PHARMACEUTICAL STERILITY TESTING MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 64 ASIA-PACIFIC: PHARMACEUTICAL STERILITY TESTING MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)
TABLE 65 ASIA-PACIFIC: PHARMACEUTICAL STERILITY TESTING MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 66 JAPAN: PHARMACEUTICAL STERILITY TESTING MARKET, BY SAMPLE, 2022–2030 (USD MILLION)
TABLE 67 JAPAN: PHARMACEUTICAL STERILITY TESTING MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)
TABLE 68 JAPAN: PHARMACEUTICAL STERILITY TESTING MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 69 JAPAN: PHARMACEUTICAL STERILITY TESTING MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)
TABLE 70 JAPAN: PHARMACEUTICAL STERILITY TESTING MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 71 CHINA: PHARMACEUTICAL STERILITY TESTING MARKET, BY SAMPLE, 2022–2030 (USD MILLION)
TABLE 72 CHINA: PHARMACEUTICAL STERILITY TESTING MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)
TABLE 73 CHINA: PHARMACEUTICAL STERILITY TESTING MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 74 CHINA: PHARMACEUTICAL STERILITY TESTING MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)
TABLE 75 CHINA: PHARMACEUTICAL STERILITY TESTING MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 76 INDIA: PHARMACEUTICAL STERILITY TESTING MARKET, BY SAMPLE, 2022–2030 (USD MILLION)
TABLE 77 INDIA: PHARMACEUTICAL STERILITY TESTING MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)
TABLE 78 INDIA: PHARMACEUTICAL STERILITY TESTING MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 79 INDIA: PHARMACEUTICAL STERILITY TESTING MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)
TABLE 80 INDIA: PHARMACEUTICAL STERILITY TESTING MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 81 AUSTRALIA: PHARMACEUTICAL STERILITY TESTING MARKET, BY SAMPLE, 2022–2030 (USD MILLION)
TABLE 82 AUSTRALIA: PHARMACEUTICAL STERILITY TESTING MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)
TABLE 83 AUSTRALIA: PHARMACEUTICAL STERILITY TESTING MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 84 AUSTRALIA: PHARMACEUTICAL STERILITY TESTING MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)
TABLE 85 AUSTRALIA: PHARMACEUTICAL STERILITY TESTING MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 86 SOUTH KOREA: PHARMACEUTICAL STERILITY TESTING MARKET, BY SAMPLE, 2022–2030 (USD MILLION)
TABLE 87 SOUTH KOREA: PHARMACEUTICAL STERILITY TESTING MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)
TABLE 88 SOUTH KOREA: PHARMACEUTICAL STERILITY TESTING MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 89 SOUTH KOREA: PHARMACEUTICAL STERILITY TESTING MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)
TABLE 90 SOUTH KOREA: PHARMACEUTICAL STERILITY TESTING MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 91 REST OF ASIA-PACIFIC: PHARMACEUTICAL STERILITY TESTING MARKET, BY SAMPLE, 2022–2030 (USD MILLION)
TABLE 92 REST OF ASIA-PACIFIC: PHARMACEUTICAL STERILITY TESTING MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)
TABLE 93 REST OF ASIA-PACIFIC: PHARMACEUTICAL STERILITY TESTING MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 94 REST OF ASIA-PACIFIC: PHARMACEUTICAL STERILITY TESTING MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)
TABLE 95 REST OF ASIA-PACIFIC: PHARMACEUTICAL STERILITY TESTING MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 96 REST OF THE WORLD: PHARMACEUTICAL STERILITY TESTING MARKET, BY REGION, 2022–2030 (USD MILLION)
TABLE 97 REST OF THE WORLD: PHARMACEUTICAL STERILITY TESTING MARKET, BY SAMPLE, 2022–2030 (USD MILLION)
TABLE 98 REST OF THE WORLD: PHARMACEUTICAL STERILITY TESTING MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)
TABLE 99 REST OF THE WORLD: PHARMACEUTICAL STERILITY TESTING MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 100 REST OF THE WORLD: PHARMACEUTICAL STERILITY TESTING MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)
TABLE 101 REST OF THE WORLD: PHARMACEUTICAL STERILITY TESTING MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 102 MIDDLE EAST: PHARMACEUTICAL STERILITY TESTING MARKET, BY SAMPLE, 2022–2030 (USD MILLION)
TABLE 103 MIDDLE EAST: PHARMACEUTICAL STERILITY TESTING MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)
TABLE 104 MIDDLE EAST: PHARMACEUTICAL STERILITY TESTING MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 105 MIDDLE EAST: PHARMACEUTICAL STERILITY TESTING MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)
TABLE 106 MIDDLE EAST: PHARMACEUTICAL STERILITY TESTING MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 107 AFRICA: PHARMACEUTICAL STERILITY TESTING MARKET, BY SAMPLE, 2022–2030 (USD MILLION)
TABLE 108 AFRICA: PHARMACEUTICAL STERILITY TESTING MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)
TABLE 109 AFRICA: PHARMACEUTICAL STERILITY TESTING MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 110 AFRICA: PHARMACEUTICAL STERILITY TESTING MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)
TABLE 111 AFRICA: PHARMACEUTICAL STERILITY TESTING MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 112 LATIN AMERICA: PHARMACEUTICAL STERILITY TESTING MARKET, BY SAMPLE, 2022–2030 (USD MILLION)
TABLE 113 LATIN AMERICA: PHARMACEUTICAL STERILITY TESTING MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION)
TABLE 114 LATIN AMERICA: PHARMACEUTICAL STERILITY TESTING MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 115 LATIN AMERICA: PHARMACEUTICAL STERILITY TESTING MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)
TABLE 116 LATIN AMERICA: PHARMACEUTICAL STERILITY TESTING MARKET, BY END USER, 2022–2030 (USD MILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET
FIGURE 4 GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET SHARE, BY SAMPLE, 2020 (%)
FIGURE 5 GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET SHARE, BY PRODUCT TYPE, 2020 (%)
FIGURE 6 GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET SHARE, BY TYPE, 2020 (%)
FIGURE 7 GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET SHARE, BY TEST TYPE, 2020 (%)
FIGURE 8 GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET SHARE, BY END USER, 2020 (%)
FIGURE 9 GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET SHARE, BY REGION, 2020 (%)
FIGURE 10 NORTH AMERICA: PHARMACEUTICAL STERILITY TESTING MARKET SHARE, BY REGION, 2020 (%)
FIGURE 11 EUROPE: PHARMACEUTICAL STERILITY TESTING MARKET SHARE, BY REGION, 2020 (%)
FIGURE 12 ASIA-PACIFIC: PHARMACEUTICAL STERILITY TESTING MARKET SHARE, BY REGION, 2020 (%)
FIGURE 13 REST OF THE WORLD: PHARMACEUTICAL STERILITY TESTING MARKET SHARE, BY REGION, 2020 (%)
FIGURE 14 GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET: COMPANY SHARE ANALYSIS, 2020 (%)
FIGURE 15 MERCK KGAA PHARMACEUTICALS: FINANCIAL OVERVIEW
FIGURE 16 MERCK KGAA PHARMACEUTICALS: SWOT ANALYSIS
FIGURE 17 RAPID MICRO BIOSYSTEMS: FINANCIAL OVERVIEW
FIGURE 18 RAPID MICRO BIOSYSTEMS: SWOT ANALYSIS
FIGURE 19 SARTORIUS AG: FINANCIAL OVERVIEW
FIGURE 20 SARTORIUS AG: SWOT ANALYSIS
FIGURE 21 SOLVIAS AG: FINANCIAL OVERVIEW
FIGURE 22 SOLVIAS AG: SWOT ANALYSIS
FIGURE 23 SGS SA: FINANCIAL OVERVIEW
FIGURE 24 SGS SA: SWOT ANALYSIS
FIGURE 25 BOSTON ANALYTICAL: FINANCIAL OVERVIEW
FIGURE 26 BOSTON ANALYTICAL: SWOT ANALYSIS
FIGURE 27 BIOMÉRIEUX, INC.: FINANCIAL OVERVIEW
FIGURE 28 BIOMÉRIEUX, INC.: SWOT ANALYSIS
FIGURE 29 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: FINANCIAL OVERVIEW
FIGURE 30 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: SWOT ANALYSIS
FIGURE 31 THERMO FISHER SCIENTIFIC, INC.: FINANCIAL OVERVIEW
FIGURE 32 THERMO FISHER SCIENTIFIC, INC.: SWOT ANALYSIS
FIGURE 33 PACE ANALYTICAL SERVICES, LLC: FINANCIAL OVERVIEW
FIGURE 34 PACE ANALYTICAL SERVICES, LLC: SWOT ANALYSIS
FIGURE 35 TOXIKON, INC.: FINANCIAL OVERVIEW
FIGURE 36 TOXIKON, INC.: SWOT ANALYSIS
FIGURE 37 SOTERA HEALTH: FINANCIAL OVERVIEW
FIGURE 38 SOTERA HEALTH: SWOT ANALYSIS
FIGURE 39 PACIFIC BIOLABS INC.: FINANCIAL OVERVIEW
FIGURE 40 PACIFIC BIOLABS INC.: SWOT ANALYSIS
FIGURE 41 STRERIS CORPORATION: FINANCIAL OVERVIEW
FIGURE 42 STRERIS CORPORATION: SWOT ANALYSIS
FIGURE 43 WUXI APPTEC: FINANCIAL OVERVIEW
FIGURE 44 WUXI APPTEC: SWOT ANALYSIS
Market Segmentation
Pharmaceutical Sterility Testing Sample Outlook (USD Billion, 2018-2032)
·        Sterile Drugs
·        Medical Devices
·        Biologics
Pharmaceutical Sterility Testing Product Type Format Outlook (USD Billion, 2018-2032)
·        Instruments
·        Kits & Reagents
·        Services
Pharmaceutical Sterility Testing Type Outlook (USD Billion, 2018-2032)
·        In-house
·        OutsourcingÂ
Pharmaceutical Sterility Testing Test Type Outlook (USD Billion, 2018-2032)
·        Sterility Testing
·        Bioburden Testing
·        Bacterial Endotoxin Testing
Pharmaceutical Sterility Testing End User Outlook (USD Billion, 2018-2032)
·        Compounding Pharmacies
·        Medical Devices Companies
·        Pharmaceutical Companies
Pharmaceutical Sterility Testing Regional Outlook (USD Billion, 2018-2032)
·        North America Outlook (USD Billion, 2018-2032)
o  North America Pharmaceutical Sterility Testing by Sample
§ Sterile Drugs
§ Medical Devices
§ Biologics
o  North America Pharmaceutical Sterility Testing by Product Type Format
§ Instruments
§ Kits & Reagents
§ Services
o  North America Pharmaceutical Sterility Testing by Type
§  In-House Â
§ OutsourcingÂ
o  North America Pharmaceutical Sterility Testing by Test Type
§  Sterility Testing
§ Bioburden Testing
§ Bacterial Endotoxin Testing
o   North America Pharmaceutical Sterility Testing by End User
§ Compounding Pharmacies
§ Medical Devices Companies
§ Pharmaceutical Companies
o  US Outlook (USD Billion, 2018-2032)
o  US Pharmaceutical Sterility Testing by Sample
§ Sterile Drugs
§ Medical Devices
§ Biologics
o  US Pharmaceutical Sterility Testing by Product Type Format
§ Instruments
§ Kits & Reagents
§ Services
o  US Pharmaceutical Sterility Testing by Type
§  In-House
§ OutsourcingÂ
o  US Pharmaceutical Sterility Testing by Test Type
§  Sterility Testing
§ Bioburden Testing
§ Bacterial Endotoxin Testing
o   US Pharmaceutical Sterility Testing by End User
§ Compounding Pharmacies
§ Medical Devices Companies
§ Pharmaceutical Companies
o  CANADA Outlook (USD Billion, 2018-2032)
o  CANADA Pharmaceutical Sterility Testing by Sample
§ Sterile Drugs
§ Medical Devices
§ Biologics
o  CANADA Pharmaceutical Sterility Testing by Product Type Format
§ Instruments
§ Kits & Reagents
§ Services
o  CANADA Pharmaceutical Sterility Testing by Type
§ In-House
§ OutsourcingÂ
o  CANADA Pharmaceutical Sterility Testing by Test Type
§  Sterility Testing
§ Bioburden Testing
§ Bacterial Endotoxin Testing
o  CANADA Pharmaceutical Sterility Testing by End User
§ Compounding Pharmacies
§ Medical Devices Companies
§ Pharmaceutical Companies
·        Europe Outlook (USD Billion, 2018-2032)
o   Europe Pharmaceutical Sterility Testing by Sample
§ Sterile Drugs
§ Medical Devices
§ Biologics
o  Europe Pharmaceutical Sterility Testing by Product Type Format
§ Instruments
§ Kits & Reagents
§ Services
o  Europe Pharmaceutical Sterility Testing by Type
§  In-House
§ OutsourcingÂ
o  Europe Pharmaceutical Sterility Testing by Test Type
§  Sterility Testing
§ Bioburden Testing
§ Bacterial Endotoxin Testing
o  Europe Pharmaceutical Sterility Testing by End User
§ Compounding Pharmacies
§ Medical Devices Companies
§ Pharmaceutical Companies
o  Germany Outlook (USD Billion, 2018-2032)
o  Germany Pharmaceutical Sterility Testing by Sample
§ Sterile Drugs
§ Medical Devices
§ Biologics
o  Germany Pharmaceutical Sterility Testing by Product Type Format
§ Instruments
§ Kits & Reagents
§ Services
o  Germany Pharmaceutical Sterility Testing by Type
§  In-House
§ OutsourcingÂ
o  Germany Pharmaceutical Sterility Testing by Test Type
§  Sterility Testing
§ Bioburden Testing
§ Bacterial Endotoxin Testing
o  Germany Pharmaceutical Sterility Testing by End User
§ Compounding Pharmacies
§ Medical Devices Companies
§ Pharmaceutical Companies
o  France Outlook (USD Billion, 2018-2032)
o  France Pharmaceutical Sterility Testing by Sample
§ Sterile Drugs
§ Medical Devices
§ Biologics
o  France Pharmaceutical Sterility Testing by Product Type Format
§ Instruments
§ Kits & Reagents
§ Services
o  France Pharmaceutical Sterility Testing by Type
§  In-House
§ OutsourcingÂ
o  France Pharmaceutical Sterility Testing by Test Type
§  Sterility Testing
§ Bioburden Testing
§ Bacterial Endotoxin Testing
o  France Pharmaceutical Sterility Testing by End User
§ Compounding Pharmacies
§ Medical Devices Companies
§ Pharmaceutical Companies
o  UK Outlook (USD Billion, 2018-2032)
o  UK Pharmaceutical Sterility Testing by Sample
§ Sterile Drugs
§ Medical Devices
§ Biologics
o  UK Pharmaceutical Sterility Testing by Product Type Format
§ Instruments
§ Kits & Reagents
§ Services
o  UK Pharmaceutical Sterility Testing by Type
§  In-House
§ OutsourcingÂ
o  UK Pharmaceutical Sterility Testing by Test Type
§  Sterility Testing
§ Bioburden Testing
§ Bacterial Endotoxin Testing
o  UK Pharmaceutical Sterility Testing by End User
§ Compounding Pharmacies
§ Medical Devices Companies
§ Pharmaceutical Companies
o  ITALY Outlook (USD Billion, 2018-2032)
o  ITALY Pharmaceutical Sterility Testing by Sample
§ Sterile Drugs
§ Medical Devices
§ Biologics
o  ITALY Pharmaceutical Sterility Testing by Product Type Format
§ Instruments
§ Kits & Reagents
§ Services
o  ITALY Pharmaceutical Sterility Testing by Type
§  In-House
§ OutsourcingÂ
o  ITALY Pharmaceutical Sterility Testing by Test Type
§  Sterility Testing
§ Bioburden Testing
§ Bacterial Endotoxin Testing
o  ITALY Pharmaceutical Sterility Testing by End User
§ Compounding Pharmacies
§ Medical Devices Companies
§ Pharmaceutical Companies
o  SPAIN Outlook (USD Billion, 2018-2032)
o  Spain Pharmaceutical Sterility Testing by Sample
§ Sterile Drugs
§ Medical Devices
§ Biologics
o  Spain Pharmaceutical Sterility Testing by Product Type Format
§ Instruments
§ Kits & Reagents
§ Services
o  Spain Pharmaceutical Sterility Testing by Type
§  In-House
§ OutsourcingÂ
o  Spain Pharmaceutical Sterility Testing by Test Type
§  Sterility Testing
§ Bioburden Testing
§ Bacterial Endotoxin Testing
o  Spain Pharmaceutical Sterility Testing by End User
§ Compounding Pharmacies
§ Medical Devices Companies
§ Pharmaceutical Companies
o  Rest Of Europe Outlook (USD Billion, 2018-2032)
o  Rest Of Europe Pharmaceutical Sterility Testing by Sample
§ Sterile Drugs
§ Medical Devices
§ Biologics
o  REST OF EUROPE Pharmaceutical Sterility Testing by Product Type Format
§ Instruments
§ Kits & Reagents
§ Services
o  REST OF EUROPE Pharmaceutical Sterility Testing by Type
§ In-House
§ OutsourcingÂ
o  REST OF EUROPE Pharmaceutical Sterility Testing by Test Type
§ Sterility Testing
§ Bioburden Testing
§ Bacterial Endotoxin Testing
o  REST OF EUROPE Pharmaceutical Sterility Testing by End User
§ Compounding Pharmacies
§ Medical Devices Companies
§ Pharmaceutical Companies
·        Asia-Pacific Outlook (USD Billion, 2018-2032)
o   Asia-Pacific Pharmaceutical Sterility Testing by Sample
§ Sterile Drugs
§ Medical Devices
§ Biologics
o  Asia-Pacific Pharmaceutical Sterility Testing by Product Type Format
§ Instruments
§ Kits & Reagents
§ Services
o  Asia-Pacific Pharmaceutical Sterility Testing by Type
§ In-house
§ OutsourcingÂ
o  Asia-Pacific Pharmaceutical Sterility Testing by Test Type
§ Sterility Testing
§ Bioburden Testing
§ Bacterial Endotoxin Testing
o  Asia-Pacific Pharmaceutical Sterility Testing by End User
§ Compounding Pharmacies
§ Medical Devices Companies
§  Pharmaceutical Companies
o  China Outlook (USD Billion, 2018-2032)
o  China Pharmaceutical Sterility Testing by Sample
§ Sterile Drugs
§ Medical Devices
§ Biologics
o  China Pharmaceutical Sterility Testing by Product Type Format
§ Instruments
§ Kits & Reagents
§ Services
o  China Pharmaceutical Sterility Testing by Type
§  In-House
§ OutsourcingÂ
o  China Pharmaceutical Sterility Testing by Test Type
§  Sterility Testing
§ Bioburden Testing
§ Bacterial Endotoxin Testing
o  China Pharmaceutical Sterility Testing by End User
§ Compounding Pharmacies
§ Medical Devices Companies
§ Pharmaceutical Companies
o  Japan Outlook (USD Billion, 2018-2032)
o  Japan Pharmaceutical Sterility Testing by Sample
§ Sterile Drugs
§ Medical Devices
§ Biologics
o  Japan Pharmaceutical Sterility Testing by Product Type Format
§ Instruments
§ Kits & Reagents
§ Services
o  Japan Pharmaceutical Sterility Testing by Type
§  In-House
§ OutsourcingÂ
o  Japan Pharmaceutical Sterility Testing by Test Type
§  Sterility Testing
§ Bioburden Testing
§ Bacterial Endotoxin Testing
o  Japan Pharmaceutical Sterility Testing by End User
§ Compounding Pharmacies
§ Medical Devices Companies
§ Pharmaceutical Companies
o  India Outlook (USD Billion, 2018-2032)
o  India Pharmaceutical Sterility Testing by Sample
§ Sterile Drugs
§ Medical Devices
§ Biologics
o  India Pharmaceutical Sterility Testing by Product Type Format
§ Instruments
§ Kits & Reagents
§ Services
o  India Pharmaceutical Sterility Testing by Type
§  In-House
§ OutsourcingÂ
o  India Pharmaceutical Sterility Testing by Test Type
§  Sterility Testing
§ Bioburden Testing
§ Bacterial Endotoxin Testing
o  India Pharmaceutical Sterility Testing by End User
§ Compounding Pharmacies
§ Medical Devices Companies
§ Pharmaceutical Companies
o  Australia Outlook (USD Billion, 2018-2032)
o  Australia Pharmaceutical Sterility Testing by Sample
§ Sterile Drugs
§ Medical Devices
§ Biologics
o  Australia Pharmaceutical Sterility Testing by Product Type Format
§ Instruments
§ Kits & Reagents
§ Services
o  Australia Pharmaceutical Sterility Testing by Type
§  In-House
§ OutsourcingÂ
o  Australia Pharmaceutical Sterility Testing by Test Type
§  Sterility Testing
§ Bioburden Testing
§ Bacterial Endotoxin Testing
o  Australia Pharmaceutical Sterility Testing by End User
§ Compounding Pharmacies
§ Medical Devices Companies
§ Pharmaceutical Companies
o  Rest of Asia-Pacific Outlook (USD Billion, 2018-2032)
o  Rest of Asia-Pacific Pharmaceutical Sterility Testing by Sample
§ Sterile Drugs
§ Medical Devices
§ Biologics
o  Rest of Asia-Pacific Pharmaceutical Sterility Testing by Product Type Format
§ Instruments
§ Kits & Reagents
§ Services
o  Rest of Asia-Pacific Pharmaceutical Sterility Testing by Type
§  In-House
§ Outsourcing Â
o  Rest of Asia-Pacific Pharmaceutical Sterility Testing by Test Type
§  Sterility Testing
§ Bioburden Testing
§ Bacterial Endotoxin Testing
o  Rest of Asia-Pacific Pharmaceutical Sterility Testing by End User
§ Compounding Pharmacies
§ Medical Devices Companies
§  Pharmaceutical Companies
·        Rest of the World Outlook (USD Billion, 2018-2032)
o   Rest of the World Pharmaceutical Sterility Testing by Sample
§ Sterile Drugs
§ Medical Devices
§ Biologics
o  Rest of the World Pharmaceutical Sterility Testing by Product Type Format
§ Instruments
§ Kits & Reagents
§ Services
o  Rest of the World Pharmaceutical Sterility Testing by Type
§  In-House
§ OutsourcingÂ
o  Rest of the World Pharmaceutical Sterility Testing by Test Type
§  Sterility Testing
§ Bioburden Testing
§ Bacterial Endotoxin Testing
o  Rest of the World Pharmaceutical Sterility Testing by End User
§ Compounding Pharmacies
§ Medical Devices Companies
§  Pharmaceutical Companies
o  Middle East Outlook (USD Billion, 2018-2032)
o  Middle East Pharmaceutical Sterility Testing by Sample
§ Sterile Drugs
§ Medical Devices
§ Biologics
o  Middle East Pharmaceutical Sterility Testing by Product Type Format
§ Instruments
§ Kits & Reagents
§ Services
o  Middle East Pharmaceutical Sterility Testing by Type
§  In-House
§ OutsourcingÂ
o  Middle East Pharmaceutical Sterility Testing by Test Type
§  Sterility Testing
§ Bioburden Testing
§ Bacterial Endotoxin Testing
o  Middle East Pharmaceutical Sterility Testing by End User
§ Compounding Pharmacies
§ Medical Devices Companies
§  Pharmaceutical Companies
o  Africa Outlook (USD Billion, 2018-2032)
o  Africa Pharmaceutical Sterility Testing by Sample
§ Sterile Drugs
§ Medical Devices
§ Biologics
o  Africa Pharmaceutical Sterility Testing by Product Type Format
§ Instruments
§ Kits & Reagents
§ Services
o  Africa Pharmaceutical Sterility Testing by Type
§  In-House
§ OutsourcingÂ
o  Africa Pharmaceutical Sterility Testing by Test Type
§  Sterility Testing
§ Bioburden Testing
§ Bacterial Endotoxin Testing
o  Africa Pharmaceutical Sterility Testing by End User
§ Compounding Pharmacies
§ Medical Devices Companies
§  Pharmaceutical Companies
o  Latin America Outlook (USD Billion, 2018-2032)
o  Latin America Pharmaceutical Sterility Testing by Sample
§ Sterile Drugs
§ Medical Devices
§ Biologics
o  Latin America Pharmaceutical Sterility Testing by Product Type Format
§ Instruments
§ Kits & Reagents
§ Services
o  Latin America Pharmaceutical Sterility Testing by Type
§  In-House
§ OutsourcingÂ
o  Latin America Pharmaceutical Sterility Testing by Test Type
§  Sterility Testing
§ Bioburden Testing
§ Bacterial Endotoxin Testing Â
o  Latin America Pharmaceutical Sterility Testing by End User
§ Compounding Pharmacies
§ Medical Devices Companies
§  Pharmaceutical Companies
Research Methodology on Pharmaceutical Sterility Testing Market
For conducting the research report on Pharmaceutical Sterility Testing Market, the market research team applies both primary and secondary research methodologies. The primary research includes in-depth interviews, surveys, and expert opinions. The secondary research methodology involves analyzing market reports and documents, company websites, and databases. The market report also provides in-depth knowledge for various industry stakeholders such as investors, regulatory organizations, vendors, and policymakers.
Primary Research:
To gather accurate information for the Pharmaceutical Sterility Testing Market report, various primary research methodologies are utilized, such as in-depth interviews, expert opinions, surveys, etc. A team of highly experienced market researchers interviewed industry experts from different parts of the world. The findings and opinions from the interviews were combined and analyzed to draw a comprehensive research report. The primary research provided a detailed analysis of various stakeholders such as producers, suppliers, regulatory bodies, and distributors in the market.
Secondary Research:
The secondary research methodology was conducted to gain an in-depth understanding of the Pharmaceutical Sterility Testing Market. The research team collected and analyzed market data from various sources such as published documents, company websites, journals, government websites, and industry magazines. The secondary research also included an in-depth analysis of the competitive landscape of the market.
Market Analysis Tools Used:
The market analysis team used advanced analytical tools such as Porter's Five Forces analysis model, Supply Chain analysis, and SWOT analysis to analyse the Pharmaceutical Sterility Testing Market. These tools helped in understanding the competitive landscape of the market and its various dynamics. The tools also aided in analysing the potential of the market, assessing its current market value, and estimating its future development.
Research Report Validation and Revision:
Once the analysis was completed, the research team conducted a series of meetings with industry experts to validate the collected data. The collected qualitative and quantitative information was validated by multiple stakeholders from the market and the results were evaluated against industry analysis techniques. After validation, the market research team revised the report as needed to ensure accuracy.
The final research report was presented to the stakeholders for their review, and any comments or observations were incorporated into the report.
Conclusion:
Using the methodologies described above, the market research team has developed a comprehensive research report on the Pharmaceutical Sterility Testing Market. The report covers the market’s key dynamics such as drivers, restraints, and opportunities. The report also provides a detailed overview of the market’s structure and a detailed analysis of the current market situation along with the market forecast for 2023 to 2030. The report also includes a detailed SWOT analysis that provides an in-depth understanding of the state of the market.